The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
High Throughput Screening (HTS)-Global Market Insights and Sales Trends 2025
Synopsis
The global High Throughput Screening (HTS) market size is expected to reach US$ 23230 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of High Throughput Screening (HTS) in various end use industries. The expanding demands from the Drug Discovery Programs, Chemical Biology Programs, Biochemical Screening and Cell- & Organ-based Screening, are propelling High Throughput Screening (HTS) market. Cell-based Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 3D - Cell Cultures segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for High Throughput Screening (HTS) market, driven by demand from China, the second largest economy with some signs of stabilising, the High Throughput Screening (HTS) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for High Throughput Screening (HTS), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global High Throughput Screening (HTS) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global High Throughput Screening (HTS) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, High Throughput Screening (HTS) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of High Throughput Screening (HTS) covered in this report include Agilent Technologies, Inc., Danaher Corporation, Thermofisher Scientific, Inc., PerkinElmer, Inc., Tecan Group Ltd., Merck Millipore, Bio-Rad Laboratories, Hamilton Company and Axxam S.p.A., etc.
The global High Throughput Screening (HTS) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies, Inc.
Danaher Corporation
Thermofisher Scientific, Inc.
PerkinElmer, Inc.
Tecan Group Ltd.
Merck Millipore
Bio-Rad Laboratories
Hamilton Company
Axxam S.p.A.
Aurora Biomed
Global High Throughput Screening (HTS) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global High Throughput Screening (HTS) market, Segment by Type:
Cell-based Assays
3D - Cell Cultures
Ultra High Throughput Screening
Global High Throughput Screening (HTS) market, by Application
Drug Discovery Programs
Chemical Biology Programs
Biochemical Screening
Cell- & Organ-based Screening
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of High Throughput Screening (HTS) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global High Throughput Screening (HTS) market size is expected to reach US$ 23230 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of High Throughput Screening (HTS) in various end use industries. The expanding demands from the Drug Discovery Programs, Chemical Biology Programs, Biochemical Screening and Cell- & Organ-based Screening, are propelling High Throughput Screening (HTS) market. Cell-based Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 3D - Cell Cultures segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for High Throughput Screening (HTS) market, driven by demand from China, the second largest economy with some signs of stabilising, the High Throughput Screening (HTS) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for High Throughput Screening (HTS), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global High Throughput Screening (HTS) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global High Throughput Screening (HTS) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, High Throughput Screening (HTS) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of High Throughput Screening (HTS) covered in this report include Agilent Technologies, Inc., Danaher Corporation, Thermofisher Scientific, Inc., PerkinElmer, Inc., Tecan Group Ltd., Merck Millipore, Bio-Rad Laboratories, Hamilton Company and Axxam S.p.A., etc.
The global High Throughput Screening (HTS) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies, Inc.
Danaher Corporation
Thermofisher Scientific, Inc.
PerkinElmer, Inc.
Tecan Group Ltd.
Merck Millipore
Bio-Rad Laboratories
Hamilton Company
Axxam S.p.A.
Aurora Biomed
Global High Throughput Screening (HTS) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global High Throughput Screening (HTS) market, Segment by Type:
Cell-based Assays
3D - Cell Cultures
Ultra High Throughput Screening
Global High Throughput Screening (HTS) market, by Application
Drug Discovery Programs
Chemical Biology Programs
Biochemical Screening
Cell- & Organ-based Screening
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of High Throughput Screening (HTS) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of High Throughput Screening (HTS)
1.1 High Throughput Screening (HTS) Market Overview
1.1.1 High Throughput Screening (HTS) Product Scope
1.1.2 High Throughput Screening (HTS) Market Status and Outlook
1.2 Global High Throughput Screening (HTS) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global High Throughput Screening (HTS) Market Size by Region (2018-2029)
1.4 Global High Throughput Screening (HTS) Historic Market Size by Region (2018-2023)
1.5 Global High Throughput Screening (HTS) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, High Throughput Screening (HTS) Market Size (2018-2029)
1.6.1 North America High Throughput Screening (HTS) Market Size (2018-2029)
1.6.2 Europe High Throughput Screening (HTS) Market Size (2018-2029)
1.6.3 Asia-Pacific High Throughput Screening (HTS) Market Size (2018-2029)
1.6.4 Latin America High Throughput Screening (HTS) Market Size (2018-2029)
1.6.5 Middle East & Africa High Throughput Screening (HTS) Market Size (2018-2029)
2 High Throughput Screening (HTS) Market by Type
2.1 Introduction
2.1.1 Cell-based Assays
2.1.2 3D - Cell Cultures
2.1.3 Ultra High Throughput Screening
2.2 Global High Throughput Screening (HTS) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global High Throughput Screening (HTS) Historic Market Size by Type (2018-2023)
2.2.2 Global High Throughput Screening (HTS) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America High Throughput Screening (HTS) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe High Throughput Screening (HTS) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific High Throughput Screening (HTS) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America High Throughput Screening (HTS) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa High Throughput Screening (HTS) Revenue Breakdown by Type (2018-2029)
3 High Throughput Screening (HTS) Market Overview by Application
3.1 Introduction
3.1.1 Drug Discovery Programs
3.1.2 Chemical Biology Programs
3.1.3 Biochemical Screening
3.1.4 Cell- & Organ-based Screening
3.2 Global High Throughput Screening (HTS) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global High Throughput Screening (HTS) Historic Market Size by Application (2018-2023)
3.2.2 Global High Throughput Screening (HTS) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America High Throughput Screening (HTS) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe High Throughput Screening (HTS) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific High Throughput Screening (HTS) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America High Throughput Screening (HTS) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa High Throughput Screening (HTS) Revenue Breakdown by Application (2018-2029)
4 High Throughput Screening (HTS) Competition Analysis by Players
4.1 Global High Throughput Screening (HTS) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in High Throughput Screening (HTS) as of 2022)
4.3 Date of Key Players Enter into High Throughput Screening (HTS) Market
4.4 Global Top Players High Throughput Screening (HTS) Headquarters and Area Served
4.5 Key Players High Throughput Screening (HTS) Product Solution and Service
4.6 Competitive Status
4.6.1 High Throughput Screening (HTS) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Agilent Technologies, Inc.
5.1.1 Agilent Technologies, Inc. Profile
5.1.2 Agilent Technologies, Inc. Main Business
5.1.3 Agilent Technologies, Inc. High Throughput Screening (HTS) Products, Services and Solutions
5.1.4 Agilent Technologies, Inc. High Throughput Screening (HTS) Revenue (US$ Million) & (2018-2023)
5.1.5 Agilent Technologies, Inc. Recent Developments
5.2 Danaher Corporation
5.2.1 Danaher Corporation Profile
5.2.2 Danaher Corporation Main Business
5.2.3 Danaher Corporation High Throughput Screening (HTS) Products, Services and Solutions
5.2.4 Danaher Corporation High Throughput Screening (HTS) Revenue (US$ Million) & (2018-2023)
5.2.5 Danaher Corporation Recent Developments
5.3 Thermofisher Scientific, Inc.
5.3.1 Thermofisher Scientific, Inc. Profile
5.3.2 Thermofisher Scientific, Inc. Main Business
5.3.3 Thermofisher Scientific, Inc. High Throughput Screening (HTS) Products, Services and Solutions
5.3.4 Thermofisher Scientific, Inc. High Throughput Screening (HTS) Revenue (US$ Million) & (2018-2023)
5.3.5 PerkinElmer, Inc. Recent Developments
5.4 PerkinElmer, Inc.
5.4.1 PerkinElmer, Inc. Profile
5.4.2 PerkinElmer, Inc. Main Business
5.4.3 PerkinElmer, Inc. High Throughput Screening (HTS) Products, Services and Solutions
5.4.4 PerkinElmer, Inc. High Throughput Screening (HTS) Revenue (US$ Million) & (2018-2023)
5.4.5 PerkinElmer, Inc. Recent Developments
5.5 Tecan Group Ltd.
5.5.1 Tecan Group Ltd. Profile
5.5.2 Tecan Group Ltd. Main Business
5.5.3 Tecan Group Ltd. High Throughput Screening (HTS) Products, Services and Solutions
5.5.4 Tecan Group Ltd. High Throughput Screening (HTS) Revenue (US$ Million) & (2018-2023)
5.5.5 Tecan Group Ltd. Recent Developments
5.6 Merck Millipore
5.6.1 Merck Millipore Profile
5.6.2 Merck Millipore Main Business
5.6.3 Merck Millipore High Throughput Screening (HTS) Products, Services and Solutions
5.6.4 Merck Millipore High Throughput Screening (HTS) Revenue (US$ Million) & (2018-2023)
5.6.5 Merck Millipore Recent Developments
5.7 Bio-Rad Laboratories
5.7.1 Bio-Rad Laboratories Profile
5.7.2 Bio-Rad Laboratories Main Business
5.7.3 Bio-Rad Laboratories High Throughput Screening (HTS) Products, Services and Solutions
5.7.4 Bio-Rad Laboratories High Throughput Screening (HTS) Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Rad Laboratories Recent Developments
5.8 Hamilton Company
5.8.1 Hamilton Company Profile
5.8.2 Hamilton Company Main Business
5.8.3 Hamilton Company High Throughput Screening (HTS) Products, Services and Solutions
5.8.4 Hamilton Company High Throughput Screening (HTS) Revenue (US$ Million) & (2018-2023)
5.8.5 Hamilton Company Recent Developments
5.9 Axxam S.p.A.
5.9.1 Axxam S.p.A. Profile
5.9.2 Axxam S.p.A. Main Business
5.9.3 Axxam S.p.A. High Throughput Screening (HTS) Products, Services and Solutions
5.9.4 Axxam S.p.A. High Throughput Screening (HTS) Revenue (US$ Million) & (2018-2023)
5.9.5 Axxam S.p.A. Recent Developments
5.10 Aurora Biomed
5.10.1 Aurora Biomed Profile
5.10.2 Aurora Biomed Main Business
5.10.3 Aurora Biomed High Throughput Screening (HTS) Products, Services and Solutions
5.10.4 Aurora Biomed High Throughput Screening (HTS) Revenue (US$ Million) & (2018-2023)
5.10.5 Aurora Biomed Recent Developments
6 North America
6.1 North America High Throughput Screening (HTS) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe High Throughput Screening (HTS) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific High Throughput Screening (HTS) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America High Throughput Screening (HTS) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa High Throughput Screening (HTS) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 High Throughput Screening (HTS) Market Dynamics
11.1 High Throughput Screening (HTS) Industry Trends
11.2 High Throughput Screening (HTS) Market Drivers
11.3 High Throughput Screening (HTS) Market Challenges
11.4 High Throughput Screening (HTS) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
